Endogenous IL-33 promotes effector CD4+ and CD8+ T cell activation and IFN-γ production to enhance antitumor responses and suppress cancer growth and metastasis in mouse models of colon and hepatocellular carcinoma [244,245,246]. Here, IL33 is linked to cancer.